2015 Acquisition International Awards, Best for Med Tech M&A-USA & Award for Innovation in PE/VC Medical Financing
Cambridge, MA - September 1, 2015
MedCap is pleased to have been awarded the 2015 ‘Best for MedTech M&A’ by AI Finance. The 2015 Finance Awards takes an inside look at the top contenders in the financial sphere, acknowledging the innovation and expertise that made them leaders in their industry.
This award is a significant milestone in a process of continual learning and improvement. While we are very pleased to receive it, it is only the beginning in achieving excellence. We believe our success is due to our long-standing industry expertise, wide spread contacts and dedication to our clients.
To ensure that our clients get the best possible service we make sure that our first priority is to provide leading edge insight into the macro and micro economic factors that impact both our investments and our clients.
MedCap is an open and collaborative organization deliberately positioned in close proximity to some of the finest universities and hospitals in the world. We recruit, collaborate and work with these organizations in an open, thoughtful and productive dialogue to continually advance our culture. In our company, every voice is heard and every comment is absorbed and evaluated, whether it is from a partner or colleague.
We are specialists in healthcare. Our firm’s highly specialized nature and years of experience have given us in-depth knowledge in the healthcare industry that is unparalleled, which sets us apart from our competitors. Our contacts give us a global reach into more than 15 countries and 5 continents, while our prime location in the Massachusetts supercluster of medical technology and established reputation connects us with some of the brightest minds in the industry.
In the past year, there have been increasing valuations from MedTech and biotech transactions in both the public markets and M&A. There has been an increasing volume of transactions and a decreasing availability of venture capital funding.
Currently, our focus is on the growth of the asset management business. We plan on increasing the number of assets under management across various stages and throughout a range of healthcare industry segments.
AI Awards Guide: bit.ly/MedCapAwards2015_AIFinance